In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by ...
A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at ...
New study from heart researchers at Intermountain Health in Salt Lake City finds that routine coronary artery calcium CT ...
Researchers from Mass General Brigham have found that olezarsen—a drug designed to lower triglyceride levels—can also decrease the risk of acute pancreatitis, a potential complication in patients with ...
A transitional dialysis program piloted in Austin, TX lowered the use ofcostly emergency dialysis in uninsured people with kidney failure, and it facilitated permanent dialysis access placement and ...
Researchers developed and validated a model that estimates individualized survival probabilities with conservative management versusdialysis in patients with advanced chronic kidney disease.
Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major ...
In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in their coronary arteries are not only ...
Expanding the waitlisting criteria for kidney transplantation to include risk ofkidney failure—rather than taking a single measurement of kidney function—could improve outcomes in younger patients and ...
A global analysis indicates that countries with higher socioeconomic status and older populations are experiencing increasing rates of acute kidneyinjury–related mortality, a trend projected to ...
Dr. Johnson V. John, Ph.D., Assistant Professor at the Terasaki Institute for Biomedical Innovation, has been appointed as a ...
A diagnosis and treatment protocol including the prompt initiation of dialysisled to reduced mortality from metformin-associated lactic acidosis at a hospital in Thailand.